Lily MedTech
- Company typePrivate
- Founded2016
- HeadquartersTokyo, Japan
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Lily MedTech firmographics
Firmographics- Name
- Lily MedTech
- Legal name
- 株式会社Lily MedTech
- Website
- https://lilymedtech.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Lily MedTech industry classification
Industry- Product category
- Breast Ultrasound Diagnostic Imaging Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Ultrasound & Echography Systems (HLAHABAD)
- akta.pro secondary industry
- Mammography & Breast Imaging Systems (HLAHABAF)
Keywords
Where Lily MedTech is headquartered
LocationHeadquarters
- HQ city
- Tokyo
- HQ country
- Japan
- HQ region
- Asia
Offices1 record
Markets served
Lily MedTech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Personnel, Operations, Supply Chain, Marketing or Sales
Revenue model
- Medical Device Sales (COCOLY): Sale of the COCOLY breast ring-shaped ultrasound imaging system to medical institutions. One-time hardware purchase model with associated installation, training, and potentially ongoing service/maintenance components.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Lily MedTech product offering
Product offeringCore offering
Lily MedTech develops and manufactures the COCOLY breast ring-shaped ultrasound imaging system, a medical diagnostic device that uses a ring-array ultrasonic transducer to perform automated, contact-free, radiation-free 3D breast imaging. The product is sold to hospitals and breast clinics in Japan through Alfresa Corporation as sole distributor, targeting breast cancer screening for women, particularly those with dense breast tissue where mammography has reduced effectiveness.
Product overview
Lily MedTech is a single-product medical device company. Its sole commercial offering is the COCOLY breast ring-shaped ultrasound imaging system, which is built on the company's proprietary USCT (Ultrasound Computed Tomography) ring-array transducer technology. The system provides automated, 3D ultrasound breast imaging in a prone position without breast compression, addressing key limitations of conventional mammography for women with dense breast tissue. No separate add-on modules, sub-products, or additional product lines are described on the company website.
Differentiator
Problem solved
Functional benefit
Brands
- COCOLY: Breast Ring-Shaped Ultrasound Imaging System - an innovative diagnostic imaging device for breast cancer detection using ring-type ultrasonic transducer technology. The system allows patients to lie face-down with their breast placed in a hole in the examination table, scanned without physical contact or radiation exposure.
Products and services
- COCOLY (Breast Ring-Shaped Ultrasound Imaging System) A ring-array ultrasonic diagnostic imaging system for breast cancer screening. The patient lies prone with her breast placed through a bed aperture; a circular ultrasonic transducer moves vertically to capture 360-degree volumetric ultrasound data, producing 3D images without breast compression or radiation exposure. Designed to reduce pain, eliminate radiation risk, and maintain imaging consistency regardless of operator skill, with automated scan parameters and suitability for dense-breast patients. Sold to hospitals and breast clinics through sole distributor Alfresa Corporation in Japan.
Quantifiable outcome
- Over half of breast cancer cases are self-detected; COCOLY aims to improve detection rates through accessible, comfortable screening that encourages regular check-ups
- +2 more outcomes
Companies that use Lily MedTech
Customer profileNamed customers5 records
Segments1 record
Ideal customer profiles1 record
Lily MedTech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature4 records
Lily MedTech partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Alfresa Corporation (アルフレッサ株式会社)flagshipSole distribution agreement for the COCOLY breast ultrasound imaging system for medical institutions throughout Japan. Alfresa is a major Japanese pharmaceutical and medical device wholesaler/distributor. The partnership also includes Alfresa's investment in Lily MedTech's Series C funding round.
Scale indicators6 records
Recent moves7 records
Expansion highlights5 records
Lily MedTech competitors and assessment
Company assessmentBroad incumbents
- GE HealthCare: Major supplier of mammography (Senographe Pristina), ultrasound (LOGIQ, Invenia ABUS automated breast ultrasound), and PACS to hospitals globally. Competes directly with COCOLY through both conventional mammography and automated breast ultrasound.
- Canon Medical Systems: Japanese imaging vendor with ultrasound (Aplio) and mammography systems. Domestic competitor in the breast imaging modality space, especially for university and large hospital customers.
- Hologic: Global leader in mammography (3Dimensions, Genius 3D MAMMOGRAPHY) and breast biopsy systems. The dominant incumbent COCOLY competes against in breast cancer screening; Hologic also sells supplementary ultrasound and is investing in AI-driven breast imaging.
- Siemens Healthineers: Mammography (MAMMOMAT) and ultrasound (ACUSON) systems provider with installed base in Japanese hospitals. A broad incumbent whose breast imaging portfolio overlaps with COCOLY's addressable market.
- Fujifilm Healthcare: Japanese imaging vendor with mammography and PACS products widely deployed in Japan. Relevant local incumbent for hospital procurement decisions where COCOLY must compete for screening-suite capital budgets.
- Konica Minolta Healthcare: Japan-headquartered medical imaging company with digital radiography, mammography, and ultrasound offerings sold to Japanese hospitals. Domestic broad incumbent for breast imaging workflows.
Direct peers
- Delphinus Medical Technologies: US-based developer of SoftVue, an automated 3D breast ultrasound tomography system that, like COCOLY, uses a ring-shaped transducer and prone-position patient workflow to image the whole breast without compression or radiation. Most directly comparable technology and clinical positioning worldwide.
- QT Ultrasound: Develops automated, radiation-free, operator-independent breast ultrasound imaging systems (QTscan) targeted at dense-breast screening. Closely aligned on the value proposition of comfortable, reproducible, automated 3D breast imaging for screening use cases.
Regional players
- Hitachi (ultrasound / FUJIFILM Healthcare after ultrasound divestment): Long-standing Japanese medical ultrasound heritage (Lily MedTech's CTO spent 13 years in Hitachi's Central Research Laboratory on medical ultrasound). Hitachi's ultrasound business is a relevant adjacent reference for engineering depth and market positioning.
Emerging players
- iCAD: Provides AI-based breast cancer detection and workflow software used alongside mammography and tomosynthesis. Indirectly comparable as a technology-layer partner or competitor to automated imaging modalities like COCOLY that increasingly rely on AI for image interpretation.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Lily MedTech social profiles
Digital presenceLily MedTech compliance and trust
Trust signalCompliance1 record
Lily MedTech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Lily MedTech leadership team
Management profileNumber of profiles
Profiles4 records
Lily MedTech funding detail
Funding detailFunding overview
Funding rounds4 records
Investors9 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Lily MedTech M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Lily MedTech
What does Lily MedTech do?
Lily MedTech develops and manufactures the COCOLY breast ring-shaped ultrasound imaging system, a medical diagnostic device that uses a ring-array ultrasonic transducer to perform automated, contact-free, radiation-free 3D breast imaging. The product is sold to hospitals and breast clinics in Japan through Alfresa Corporation as sole distributor, targeting breast cancer screening for women, particularly those with dense breast tissue where mammography has reduced effectiveness.
Is Lily MedTech a public or private company?
Lily MedTech is a private company. It is classified as venture growth investor backed and is currently operating.
When was Lily MedTech founded?
Lily MedTech was founded in 2016. It employs 11 to 50 people.
Where is Lily MedTech based?
Lily MedTech is headquartered in Tokyo, Japan, in the Asia region.
How does Lily MedTech make money?
One revenue line is on record: medical Device Sales (COCOLY).
Who are Lily MedTech's main competitors?
Broad incumbents on record are GE HealthCare, Canon Medical Systems, Hologic, Siemens Healthineers, Fujifilm Healthcare and Konica Minolta Healthcare. Direct peers are Delphinus Medical Technologies and QT Ultrasound. Hitachi (ultrasound / FUJIFILM Healthcare after ultrasound divestment) is listed as a regional player. iCAD is listed as an emerging player.
Does Lily MedTech have an API?
No public API is recorded for Lily MedTech.
What industry is Lily MedTech in?
Lily MedTech's product category is Breast Ultrasound Diagnostic Imaging Devices. Its primary akta.pro industry code is HLAHABAD, Ultrasound & Echography Systems, with a secondary code of HLAHABAF, Mammography & Breast Imaging Systems. Its NAICS code is 334510 and its SIC code is 3841.